Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: J Orthop Res. 2011 Mar 29;29(10):1521–1527. doi: 10.1002/jor.21408

Fig. 7.

Fig. 7

Sh3bp2(−/−) BMMs formed smaller osteoclasts with less TRAP staining and novel external cell membrane protrusions than wild-type BMMs. BMMs were treated with RANKL (100ng/ml) and m-CSF (30ng/ml) and osteoclast size, density of TRAP staining and osteoclast area (by F-actin staining) were analyzed and revealed significant differences.